{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T07:13:38Z","timestamp":1793258018593,"version":"4.5.0"},"reference-count":140,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T00:00:00Z","timestamp":1559520000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T00:00:00Z","timestamp":1559520000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s10072-019-03930-3","type":"journal-article","created":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T03:02:47Z","timestamp":1559530967000},"page":"2017-2030","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Management of antibody-mediated autoimmune encephalitis in adults and children: literature review and consensus-based practical recommendations"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7922-9024","authenticated-orcid":false,"given":"Luigi","family":"Zuliani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Nosadini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Gastaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Spatola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Iorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Zoccarato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Mariotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piera","family":"De Gaspari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Perini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Evoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Sartori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Franciotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Giometto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,3]]},"reference":[{"key":"3930_CR1","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1708712","volume":"378","author":"J Dalmau","year":"2018","unstructured":"Dalmau J, Graus F (2018) Antibody-mediated encephalitis. N Engl J Med 378:840\u2013851. \n                    https:\/\/doi.org\/10.1056\/NEJMra1708712","journal-title":"N Engl J Med"},{"key":"3930_CR2","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1136\/jnnp-2011-301237","volume":"83","author":"L Zuliani","year":"2012","unstructured":"Zuliani L, Graus F, Giometto B et al (2012) Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition. J Neurol Neurosurg Psychiatry 83:638\u2013645. \n                    https:\/\/doi.org\/10.1136\/jnnp-2011-301237","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3930_CR3","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/S1473-3099(10)70222-X","volume":"10","author":"J Granerod","year":"2010","unstructured":"Granerod J, Ambrose HE, Davies NWS et al (2010) Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 10:835\u2013844. \n                    https:\/\/doi.org\/10.1016\/S1473-3099(10)70222-X","journal-title":"Lancet Infect Dis"},{"issue":"14","key":"3930_CR4","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1212\/WNL.0000000000003173","volume":"87","author":"A v Sonderen","year":"2016","unstructured":"Sonderen A v, Coenders EC, Sanchez E et al (2016) Anti-LGI1 encephalitis. Neurology 87(14):1449\u20131456","journal-title":"Neurology"},{"key":"3930_CR5","doi-asserted-by":"publisher","unstructured":"Binks SNM, Klein CJ, Waters P et al (2017) LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes. J Neurol Neurosurg Psychiatry 1\u20139. \n                    https:\/\/doi.org\/10.1136\/jnnp-2017-315720","DOI":"10.1136\/jnnp-2017-315720"},{"key":"3930_CR6","doi-asserted-by":"publisher","unstructured":"Dubey AD, Pittock SJ, Kelly CR et al (2018) Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis. Ann Neurol 83(1):166\u2013177. \n                    https:\/\/doi.org\/10.1002\/ana.25131","DOI":"10.1002\/ana.25131"},{"key":"3930_CR7","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus F, Titulaer MJ, Balu R et al (2016) A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 15:391\u2013404. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(15)00401-9","journal-title":"Lancet Neurol"},{"key":"3930_CR8","doi-asserted-by":"publisher","unstructured":"Dalmau J (2016) NMDA receptor encephalitis and other antibody-mediated disorders of the synapse. Neurology:2471\u20132482. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000003414","DOI":"10.1212\/WNL.0000000000003414"},{"key":"3930_CR9","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/nyas.12553","volume":"1338","author":"F Leypoldt","year":"2015","unstructured":"Leypoldt F, Armangue T, Dalmau J (2015) Autoimmune encephalopathies. Ann N Y Acad Sci 1338:94\u2013114. \n                    https:\/\/doi.org\/10.1111\/nyas.12553","journal-title":"Ann N Y Acad Sci"},{"key":"3930_CR10","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","volume":"7","author":"J Dalmau","year":"2008","unstructured":"Dalmau J, Gleichman AJ, Hughes EG et al (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7:1091\u20131098. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(08)70224-2","journal-title":"Lancet Neurol"},{"key":"3930_CR11","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","volume":"12","author":"MJ Titulaer","year":"2013","unstructured":"Titulaer MJ, McCracken L, Gabilondo I et al (2013) Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: An observational cohort study. Lancet Neurol 12:157\u2013165. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(12)70310-1","journal-title":"Lancet Neurol"},{"key":"3930_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/ana.21756","volume":"66","author":"NR Florance","year":"2009","unstructured":"Florance NR, Davis RL, Lam C et al (2009) Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 66:11\u201318. \n                    https:\/\/doi.org\/10.1002\/ana.21756","journal-title":"Ann Neurol"},{"key":"3930_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/ana.21050","volume":"61","author":"J Dalmau","year":"2007","unstructured":"Dalmau J, T\u00fcz\u00fcn E, Wu HY et al (2007) Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61:25\u201336. \n                    https:\/\/doi.org\/10.1002\/ana.21050","journal-title":"Ann Neurol"},{"key":"3930_CR14","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1212\/WNL.0000000000001682","volume":"84","author":"R H\u00f6ftberger","year":"2015","unstructured":"H\u00f6ftberger R, van Sonderen A, Leypoldt F et al (2015) Encephalitis and AMPA receptor antibodies: novel findings in a case series of 22 patients. Neurology 84:2403\u20132412. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000001682","journal-title":"Neurology"},{"key":"3930_CR15","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/ana.21589","volume":"65","author":"M Lai","year":"2009","unstructured":"Lai M, Hughes EG, Peng X et al (2009) AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 65:424\u2013434. \n                    https:\/\/doi.org\/10.1002\/ana.21589","journal-title":"Ann Neurol"},{"key":"3930_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S1474-4422(09)70324-2","volume":"9","author":"E Lancaster","year":"2010","unstructured":"Lancaster E, Lai M, Peng X et al (2010) Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol 9:67\u201376. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(09)70324-2","journal-title":"Lancet Neurol"},{"key":"3930_CR17","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1212\/WNL.0b013e3182a9585f","volume":"81","author":"R H\u00f6ftberger","year":"2013","unstructured":"H\u00f6ftberger R, Titulaer MJ, Sabater L et al (2013) Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients. Neurology 81:1500\u20131506. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e3182a9585f","journal-title":"Neurology"},{"key":"3930_CR18","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1212\/WNL.0b013e3182a35271","volume":"81","author":"OJ Jeffery","year":"2013","unstructured":"Jeffery OJ, Lennon VA, Pittock SJ et al (2013) GABAB receptor autoantibody frequency in service serologic evaluation. Neurology 81:882\u2013887. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e3182a35271","journal-title":"Neurology"},{"key":"3930_CR19","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1093\/brain\/awq213","volume":"133","author":"SR Irani","year":"2010","unstructured":"Irani SR, Alexander S, Waters P, Kleopa KA, Pettingill P, Zuliani L, Peles E, Buckley C, Lang B, Vincent A (2010) Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan\u2019s syndrome and acquired neuromyotonia. Brain 133:2734\u20132748. \n                    https:\/\/doi.org\/10.1093\/brain\/awq213","journal-title":"Brain"},{"key":"3930_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1474-4422(10)70137-X","volume":"9","author":"M Lai","year":"2010","unstructured":"Lai M, Huijbers MGM, Lancaster E et al (2010) Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 9:1\u201310. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(10)70137-X","journal-title":"Lancet Neurol"},{"key":"3930_CR21","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1212\/WNL.0000000000003173","volume":"87","author":"A Van Sonderen","year":"2016","unstructured":"Van Sonderen A, Thijs RD, Coenders EC et al (2016) Anti-LGI1 encephalitis: clinical syndrome and long-term follow-up. Neurology 87:1449\u20131456. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000003173","journal-title":"Neurology"},{"issue":"8","key":"3930_CR22","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1212\/WNL.0000000000003009","volume":"87","author":"H Arino","year":"2016","unstructured":"Arino H, Armangu\u00e9 T, Petit-pedrol M et al (2016) Anti-LGI1 \u2013 associated cognitive impairment. Neurology 87(8):759\u2013765. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000003009","journal-title":"Neurology"},{"key":"3930_CR23","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/ana.23577","volume":"72","author":"SR Irani","year":"2012","unstructured":"Irani SR, Pettingill P, Kleopa KA et al (2012) Morvan syndrome: clinical and serological observations in 29 cases. Ann Neurol 72:241\u2013255. \n                    https:\/\/doi.org\/10.1002\/ana.23577","journal-title":"Ann Neurol"},{"key":"3930_CR24","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1136\/jnnp-2011-301506","volume":"83","author":"EBE Becker","year":"2012","unstructured":"Becker EBE, Zuliani L, Pettingill R et al (2012) Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia. J Neurol Neurosurg Psychiatry 83:437\u2013440. \n                    https:\/\/doi.org\/10.1136\/jnnp-2011-301506","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3930_CR25","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/ana.22297","volume":"69","author":"E Lancaster","year":"2011","unstructured":"Lancaster E, Huijbers MGM, Bar V et al (2011) Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol 69:303\u2013311. \n                    https:\/\/doi.org\/10.1002\/ana.22297","journal-title":"Ann Neurol"},{"key":"3930_CR26","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1001\/jamaneurol.2016.1585","volume":"73","author":"B Joubert","year":"2016","unstructured":"Joubert B, Saint-Martin M, Noraz N et al (2016) Characterization of a subtype of autoimmune encephalitis with anti-Contactin-associated protein-like 2 antibodies in the cerebrospinal fluid, prominent limbic symptoms, and seizures. JAMA Neurol 73:1115\u20131124. \n                    https:\/\/doi.org\/10.1001\/jamaneurol.2016.1585","journal-title":"JAMA Neurol"},{"key":"3930_CR27","doi-asserted-by":"publisher","unstructured":"Sonderen A Van, Ari\u00f1o H, Petit-pedrol M, et al (2016) The clinical spectrum of Caspr2 antibody \u2013 associated disease. Neurology 87(5):521\u2013528. \n                    https:\/\/doi.org\/10.1212\/WNL","DOI":"10.1212\/WNL"},{"key":"3930_CR28","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/S1474-4422(13)70299-0","volume":"13","author":"M Petit-Pedrol","year":"2014","unstructured":"Petit-Pedrol M, Armangue T, Peng X et al (2014) Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies. Lancet Neurol 13:276\u2013286. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(13)70299-0","journal-title":"Lancet Neurol"},{"key":"3930_CR29","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1212\/WNL.0000000000003713","volume":"88","author":"M Spatola","year":"2017","unstructured":"Spatola M, Petit-Pedrol M, Simabukuro MM et al (2017) Investigations in GABAAreceptor antibody-associated encephalitis. Neurology 88:1012\u20131020. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000003713","journal-title":"Neurology"},{"key":"3930_CR30","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/ana.23756","volume":"73","author":"A Boronat","year":"2013","unstructured":"Boronat A, Gelfand JM, Gresa-Arribas N et al (2013) Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels. Ann Neurol 73:120\u2013128. \n                    https:\/\/doi.org\/10.1002\/ana.23756","journal-title":"Ann Neurol"},{"key":"3930_CR31","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1212\/WNL.0000000000000991","volume":"83","author":"WO Tobin","year":"2014","unstructured":"Tobin WO, Lennon VA, Komorowski L et al (2014) DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients. Neurology 83:1797\u20131803. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000000991","journal-title":"Neurology"},{"key":"3930_CR32","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1212\/WNL.0000000000000372","volume":"82","author":"B Balint","year":"2014","unstructured":"Balint B, Jarius S, Nagel S et al (2014) Progressive encephalomyelitis with rigidity and myoclonus: a new variant with DPPX antibodies. Neurology 82:1521\u20131528. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000000372","journal-title":"Neurology"},{"key":"3930_CR33","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.1093\/brain\/aws256","volume":"135","author":"RC Dale","year":"2012","unstructured":"Dale RC, Merheb V, Pillai S et al (2012) Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders. Brain 135:3453\u20133468. \n                    https:\/\/doi.org\/10.1093\/brain\/aws256","journal-title":"Brain"},{"key":"3930_CR34","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1212\/WNL.0b013e3182364a44","volume":"77","author":"E Lancaster","year":"2011","unstructured":"Lancaster E, Martinez-Hernandez E, Titulaer MJ et al (2011) Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome. Neurology 77:1698\u20131701. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e3182364a44","journal-title":"Neurology"},{"key":"3930_CR35","doi-asserted-by":"publisher","first-page":"e1964","DOI":"10.1212\/WNL.0000000000005614","volume":"90","author":"M Spatola","year":"2018","unstructured":"Spatola M, Sabater L, Planagum\u00e0 J et al (2018) Encephalitis with mGluR5 antibodies: symptoms and antibody effects. Neurology 90:e1964\u2013e1972. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000005614","journal-title":"Neurology"},{"key":"3930_CR36","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1212\/WNL.0000000000002775","volume":"86","author":"N Gresa-Arribas","year":"2016","unstructured":"Gresa-Arribas N, Planagum\u00e0 J, Petit-Pedrol M et al (2016) Human neurexin-3\u03b1 antibodies associate with encephalitis and alter synapse development. Neurology 86:2235\u20132242. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000002775","journal-title":"Neurology"},{"key":"3930_CR37","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1212\/01.wnl.0000327606.50322.f0","volume":"71","author":"M Hutchinson","year":"2008","unstructured":"Hutchinson M, Waters P, McHugh J et al (2008) Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody. Neurology 71:1291\u20131292. \n                    https:\/\/doi.org\/10.1212\/01.wnl.0000327606.50322.f0","journal-title":"Neurology"},{"key":"3930_CR38","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1001\/jamaneurol.2013.574","volume":"70","author":"A McKeon","year":"2013","unstructured":"McKeon A, Martinez-Hernandez E, Lancaster E et al (2013) Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype. JAMA Neurol 70:44\u201350. \n                    https:\/\/doi.org\/10.1001\/jamaneurol.2013.574","journal-title":"JAMA Neurol"},{"key":"3930_CR39","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1093\/brain\/awu142","volume":"137","author":"A Carvajal-Gonz\u00e1lez","year":"2014","unstructured":"Carvajal-Gonz\u00e1lez A, Leite MI, Waters P et al (2014) Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes. Brain 137:2178\u20132192. \n                    https:\/\/doi.org\/10.1093\/brain\/awu142","journal-title":"Brain"},{"key":"3930_CR40","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1212\/NXI.0000000000000016","volume":"1","author":"L Zuliani","year":"2014","unstructured":"Zuliani L, Ferlazzo E, Andrigo C et al (2014) Glycine receptor antibodies in 2 cases of new, adult-onset epilepsy. Neurol Neuroimmunol Neuroinflammation 1:e16. \n                    https:\/\/doi.org\/10.1212\/NXI.0000000000000016","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"3930_CR41","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/ana.24858","volume-title":"Anti-LGI1 encephalitis is strongly associated with HLA-DR7 and HLA-DRB4","author":"A van Sonderen","year":"2017","unstructured":"van Sonderen A, Roelen DL, Stoop JA, et al (2017) Anti-LGI1 encephalitis is strongly associated with HLA-DR7 and HLA-DRB4. 81:193\u2013198. \n                    https:\/\/doi.org\/10.1002\/ana.24858"},{"key":"3930_CR42","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/ana.24860","volume":"81","author":"TJ Kim","year":"2017","unstructured":"Kim TJ, Lee ST, Moon J, Sunwoo JS, Byun JI, Lim JA, Shin YW, Jun JS, Lee HS, Lee WJ, Yang AR, Choi Y, Park KI, Jung KH, Jung KY, Kim M, Lee SK, Chu K (2017) Anti-LGI1 encephalitis is associated with unique HLA subtypes. Ann Neurol 81:183\u2013192. \n                    https:\/\/doi.org\/10.1002\/ana.24860","journal-title":"Ann Neurol"},{"key":"3930_CR43","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1093\/brain\/awy109","volume":"141","author":"S Binks","year":"2018","unstructured":"Binks S, Varley J, Lee W, Makuch M, Elliott K, Gelfand JM, Jacob S, Leite MI, Maddison P, Chen M, Geschwind MD, Grant E, Sen A, Waters P, McCormack M, Cavalleri GL, Barnardo M, Knight JC, Irani SR (2018) Distinct HLA associations of LGI1 and CASPR2-antibody diseases. Brain 141:2263\u20132271. \n                    https:\/\/doi.org\/10.1093\/brain\/awy109","journal-title":"Brain"},{"key":"3930_CR44","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1212\/WNL.0000000000003887","volume":"88","author":"C Gaig","year":"2017","unstructured":"Gaig C, Graus F, Compta Y et al (2017) Clinical manifestations of the anti-IgLON5 disease. Neurology 88:1736\u20131743. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000003887","journal-title":"Neurology"},{"key":"3930_CR45","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/ana.22307","volume":"69","author":"SR Irani","year":"2011","unstructured":"Irani SR, Michell AW, Lang B et al (2011) Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol 69:892\u2013900. \n                    https:\/\/doi.org\/10.1002\/ana.22307","journal-title":"Ann Neurol"},{"key":"3930_CR46","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1093\/brain\/awt212","volume":"136","author":"SR Irani","year":"2013","unstructured":"Irani SR, Stagg CJ, Schott JM et al (2013) Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype. Brain 136:3151\u20133162. \n                    https:\/\/doi.org\/10.1093\/brain\/awt212","journal-title":"Brain"},{"key":"3930_CR47","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/ana.21917","volume":"67","author":"MP Malter","year":"2010","unstructured":"Malter MP, Helmstaedter C, Urbach H et al (2010) Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann Neurol 67:470\u2013478. \n                    https:\/\/doi.org\/10.1002\/ana.21917","journal-title":"Ann Neurol"},{"key":"3930_CR48","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1111\/ene.13661","volume":"25","author":"F Graus","year":"2018","unstructured":"Graus F, Escudero D, Oleaga L et al (2018) Syndrome and outcome of antibody-negative limbic encephalitis. Eur J Neurol 25:1011\u20131016. \n                    https:\/\/doi.org\/10.1111\/ene.13661","journal-title":"Eur J Neurol"},{"key":"3930_CR49","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1177\/1352458513484547","volume":"19","author":"LB Krupp","year":"2013","unstructured":"Krupp LB, Tardieu M, Amato MP, Banwell B, Chitnis T, Dale RC, Ghezzi A, Hintzen R, Kornberg A, Pohl D, Rostasy K, Tenembaum S, Wassmer E, for the International Pediatric Multiple Sclerosis Study Group (2013) International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler 19:1261\u20131267. \n                    https:\/\/doi.org\/10.1177\/1352458513484547","journal-title":"Mult Scler"},{"key":"3930_CR50","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jinf.2011.11.014","volume":"64","author":"T Solomon","year":"2012","unstructured":"Solomon T, Michael BD, Smith PE et al (2012) Management of suspected viral encephalitis in adults - Association of British Neurologists and British Infection Association National Guidelines. J Inf Secur 64:347\u2013373. \n                    https:\/\/doi.org\/10.1016\/j.jinf.2011.11.014","journal-title":"J Inf Secur"},{"key":"3930_CR51","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1093\/cid\/cit458","volume":"57","author":"A Venkatesan","year":"2013","unstructured":"Venkatesan A, Tunkel AR, Bloch KC et al (2013) Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect Dis 57:1114\u20131128. \n                    https:\/\/doi.org\/10.1093\/cid\/cit458","journal-title":"Clin Infect Dis"},{"key":"3930_CR52","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s13311-016-0433-7","volume":"13","author":"MJ Bradshaw","year":"2016","unstructured":"Bradshaw MJ, Venkatesan A (2016) Herpes simplex virus-1 encephalitis in adults: pathophysiology, diagnosis, and management. Neurotherapeutics 13:493\u2013508. \n                    https:\/\/doi.org\/10.1007\/s13311-016-0433-7","journal-title":"Neurotherapeutics"},{"key":"3930_CR53","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/B978-1-4377-1604-7.00422-X","volume":"379","author":"KL Tyler","year":"2018","unstructured":"Tyler KL (2018) Acute viral encephalitis. N Engl J Med 379:557\u2013566. \n                    https:\/\/doi.org\/10.1016\/B978-1-4377-1604-7.00422-X","journal-title":"N Engl J Med"},{"key":"3930_CR54","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3851\/IMP2683","volume":"19","author":"C Ramos-Estebanez","year":"2014","unstructured":"Ramos-Estebanez C, Lizarraga KJ, Merenda A (2014) A systematic review on the role of adjunctive corticosteroids in herpes simplex virus encephalitis: is timing critical for safety and efficacy. Antivir Ther 19:133\u2013139. \n                    https:\/\/doi.org\/10.3851\/IMP2683","journal-title":"Antivir Ther"},{"key":"3930_CR55","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S0140-6736(18)32526-1","volume":"393","author":"A Venkatesan","year":"2019","unstructured":"Venkatesan A, Michael BD, Probasco JC et al (2019) Acute encephalitis in immunocompetent adults. Lancet 393:702\u2013716. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(18)32526-1","journal-title":"Lancet"},{"key":"3930_CR56","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S1474-4422(18)30244-8","volume":"17","author":"T Armangue","year":"2018","unstructured":"Armangue T, Spatola M, Vlagea A et al (2018) Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis. Lancet Neurol 17:760\u2013772. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(18)30244-8","journal-title":"Lancet Neurol"},{"key":"3930_CR57","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/dmcn.13448","volume":"59","author":"M Nosadini","year":"2017","unstructured":"Nosadini M, Mohammad SS, Corazza F et al (2017) Herpes simplex virus-induced anti- N-methyl-D-aspartate receptor encephalitis: a systematic literature review with analysis of 43 cases. Dev Med Child Neurol 59:796\u2013805. \n                    https:\/\/doi.org\/10.1111\/dmcn.13448","journal-title":"Dev Med Child Neurol"},{"key":"3930_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2019.03.011","volume":"332","author":"E Cavaliere","year":"2019","unstructured":"Cavaliere E, Nosadini M, Federica M et al (2019) Anti-NMDAR encephalitis preceded by non-herpetic central nervous system infection : systematic literature review and first case of tick-borne encephalitis triggering anti-NMDAR encephalitis. J Neuroimmunol 332:1\u20137. \n                    https:\/\/doi.org\/10.1016\/j.jneuroim.2019.03.011","journal-title":"J Neuroimmunol"},{"key":"3930_CR59","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1056\/NEJMra1801490","volume":"379","author":"JA Lieberman","year":"2018","unstructured":"Lieberman JA, First MB (2018) Psychotic disorders. N Engl J Med 379:270\u2013280. \n                    https:\/\/doi.org\/10.1056\/NEJMra1801490","journal-title":"N Engl J Med"},{"key":"3930_CR60","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S2215-0366(19)30001-X","volume":"6","author":"A Al-diwani","year":"2019","unstructured":"Al-diwani A, Handel A, Townsend L et al (2019) The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data. Lancet Psychiatry 6:235\u2013246. \n                    https:\/\/doi.org\/10.1016\/S2215-0366(19)30001-X","journal-title":"Lancet Psychiatry"},{"key":"3930_CR61","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1212\/01.CON.0000415431.07019.c2","volume":"18","author":"JA Frontera","year":"2012","unstructured":"Frontera JA (2012) Metabolic encephalopathies in the critical care unit. Contin Lifelong Learn Neurol 18:611\u2013639. \n                    https:\/\/doi.org\/10.1212\/01.CON.0000415431.07019.c2","journal-title":"Contin Lifelong Learn Neurol"},{"key":"3930_CR62","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1001\/jamaneurol.2013.592","volume":"70","author":"CJ Klein","year":"2013","unstructured":"Klein CJ, Lennon VA, Aston PA et al (2013) Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping. JAMA Neurol 70:229\u2013234. \n                    https:\/\/doi.org\/10.1001\/jamaneurol.2013.592","journal-title":"JAMA Neurol"},{"key":"3930_CR63","doi-asserted-by":"publisher","unstructured":"Gastaldi M, Zardini E, Leante R, et al (2017) Cerebrospinal fluid analysis and the determination of oligoclonal bands. 38:217\u2013224. \n                    https:\/\/doi.org\/10.1007\/s10072-017-3034-2","DOI":"10.1007\/s10072-017-3034-2"},{"key":"3930_CR64","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/WNP.0b013e31821c33a0","volume":"28","author":"PW Kaplan","year":"2011","unstructured":"Kaplan PW, Rossetti AO (2011) EEG patterns and imaging correlations in encephalopathy: encephalopathy part II. J Clin Neurophysiol 28:233\u2013251. \n                    https:\/\/doi.org\/10.1097\/WNP.0b013e31821c33a0","journal-title":"J Clin Neurophysiol"},{"key":"3930_CR65","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/WCO.0000000000000449","volume":"30","author":"M Spatola","year":"2017","unstructured":"Spatola M, Dalmau J (2017) Seizures and risk of epilepsy in autoimmune and other inflammatory encephalitis. Curr Opin Neurol 30:345\u2013353. \n                    https:\/\/doi.org\/10.1097\/WCO.0000000000000449","journal-title":"Curr Opin Neurol"},{"key":"3930_CR66","doi-asserted-by":"publisher","unstructured":"Nosadini M, Boniver C, Zuliani L et al (2015) Longitudinal electroencephalographic (EEG) findings in pediatric anti-N-methyl-D-aspartate (anti-NMDA) receptor encephalitis: the Padua experience. J Child Neurol 30. \n                    https:\/\/doi.org\/10.1177\/0883073813515947","DOI":"10.1177\/0883073813515947"},{"key":"3930_CR67","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.clinph.2005.12.007","volume":"117","author":"H Wieser","year":"2006","unstructured":"Wieser H, Schindler K, Zumsteg D (2006) EEG in Creutzfeldt\u2013Jakob disease. Clin Neurophysiol 117:935\u2013951. \n                    https:\/\/doi.org\/10.1016\/j.clinph.2005.12.007","journal-title":"Clin Neurophysiol"},{"key":"3930_CR68","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1136\/jnnp.45.5.418","volume":"45","author":"CH Wulff","year":"1982","unstructured":"Wulff CH (1982) Subacute sclerosing panencephalitis: serial electroencephalographic studies. J Neurol Neurosurg Psychiatry 45:418\u2013421. \n                    https:\/\/doi.org\/10.1136\/jnnp.45.5.418","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3930_CR69","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1086\/589747","volume":"47","author":"AR Tunkel","year":"2008","unstructured":"Tunkel AR, Glaser CA, Bloch KC et al (2008) The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 47:303\u2013327. \n                    https:\/\/doi.org\/10.1086\/589747","journal-title":"Clin Infect Dis"},{"key":"3930_CR70","doi-asserted-by":"publisher","unstructured":"Zoccarato M, Valeggia S, Zuliani L, et al (2019) Conventional brain MRI features distinguishing limbic encephalitis from mesial temporal glioma. Neuroradiology. \n                    https:\/\/doi.org\/10.1007\/s00234-019-02212-1","DOI":"10.1007\/s00234-019-02212-1"},{"key":"3930_CR71","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S1474-4422(09)70324-2","volume":"9","author":"E Lancaster","year":"2010","unstructured":"Lancaster E, Lai M, Peng X et al (2010) Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol 9:67\u201376. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(09)70324-2","journal-title":"Lancet Neurol"},{"key":"3930_CR72","doi-asserted-by":"publisher","unstructured":"Spatola M, Petit-Pedrol M, Simabukuro MM et al (2017) Investigations in GABA A receptor antibody-associated encephalitis. Neurology. 88(11):1012\u20131020. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000003713","DOI":"10.1212\/WNL.0000000000003713"},{"key":"3930_CR73","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","volume":"10","author":"J Dalmau","year":"2011","unstructured":"Dalmau J, Lancaster E, Martinez-Hernandez E et al (2011) Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 10:63\u201374. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(10)70253-2","journal-title":"Lancet Neurol"},{"key":"3930_CR74","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/ana.24117","volume":"75","author":"MJ Titulaer","year":"2014","unstructured":"Titulaer MJ, H\u00f6ftberger R, Iizuka T et al (2014) Overlapping demyelinating syndromes and anti-N-methyl-D-aspartate receptor encephalitis. Ann Neurol 75:411\u2013428. \n                    https:\/\/doi.org\/10.1002\/ana.24117","journal-title":"Ann Neurol"},{"key":"3930_CR75","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1159\/000358820","volume":"6","author":"S Mariotto","year":"2014","unstructured":"Mariotto S, Tamburin S, Salviati A et al (2014) Anti-N-methyl-D-aspartate receptor encephalitis causing a prolonged depressive disorder evolving to inflammatory brain disease. Case Rep Neurol 6:38\u201343. \n                    https:\/\/doi.org\/10.1159\/000358820","journal-title":"Case Rep Neurol"},{"key":"3930_CR76","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.soc.2014.07.004","volume":"23","author":"D Chourmouzi","year":"2014","unstructured":"Chourmouzi D, Papadopoulou E, Marias K, Drevelegas A (2014) Imaging of brain tumors. Surg Oncol Clin N Am 23:629\u2013684. \n                    https:\/\/doi.org\/10.1016\/j.soc.2014.07.004","journal-title":"Surg Oncol Clin N Am"},{"key":"3930_CR77","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1007\/s00415-013-7048-2","volume":"260","author":"A Baumgartner","year":"2013","unstructured":"Baumgartner A, Rauer S, Mader I, Meyer PT (2013) Cerebral FDG-PET and MRI findings in autoimmune limbic encephalitis: correlation with autoantibody types. J Neurol 260:2744\u20132753. \n                    https:\/\/doi.org\/10.1007\/s00415-013-7048-2","journal-title":"J Neurol"},{"key":"3930_CR78","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/1471-2377-14-136","volume":"14","author":"F Wegner","year":"2014","unstructured":"Wegner F, Wilke F, Raab P et al (2014) Anti-leucine rich glioma inactivated 1 protein and anti-N-methyl-D-aspartate receptor encephalitis show distinct patterns of brain glucose metabolism in 18F-fluoro-2-deoxy-d-glucose positron emission tomography. BMC Neurol 14:136\u2013147. \n                    https:\/\/doi.org\/10.1186\/1471-2377-14-136","journal-title":"BMC Neurol"},{"key":"3930_CR79","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1001\/jamaneurol.2014.2956","volume":"72","author":"F Leypoldt","year":"2015","unstructured":"Leypoldt F, H\u00f6ftberger R, Titulaer MJ et al (2015) Investigations on CXCL13 in anti\u2013N-methyl-D-aspartate receptor encephalitis. JAMA Neurol 72:180. \n                    https:\/\/doi.org\/10.1001\/jamaneurol.2014.2956","journal-title":"JAMA Neurol"},{"key":"3930_CR80","doi-asserted-by":"publisher","first-page":"e352","DOI":"10.1212\/NXI.0000000000000352","volume":"4","author":"JC Probasco","year":"2017","unstructured":"Probasco JC, Solnes L, Nalluri A et al (2017) Abnormal brain metabolism on FDG-PET\/CT is a common early finding in autoimmune encephalitis. Neurol - Neuroimmunol Neuroinflammation 4:e352. \n                    https:\/\/doi.org\/10.1212\/NXI.0000000000000352","journal-title":"Neurol - Neuroimmunol Neuroinflammation"},{"key":"3930_CR81","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1093\/brain\/awh526","volume":"128","author":"BM Ances","year":"2005","unstructured":"Ances BM, Vitaliani R, Taylor RA et al (2005) Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain 128:1764\u20131777. \n                    https:\/\/doi.org\/10.1093\/brain\/awh526","journal-title":"Brain"},{"key":"3930_CR82","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.neuroscience.2015.05.037","volume":"309","author":"J Heine","year":"2015","unstructured":"Heine J, Pr\u00fcss H, Bartsch T, Ploner CJ, Paul F, Finke C (2015) Imaging of autoimmune encephalitis - relevance for clinical practice and hippocampal function. Neuroscience 309:68\u201383. \n                    https:\/\/doi.org\/10.1016\/j.neuroscience.2015.05.037","journal-title":"Neuroscience"},{"key":"3930_CR83","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jneuroim.2014.04.002","volume":"271","author":"M Spatola","year":"2014","unstructured":"Spatola M, Stojanova V, Prior JO et al (2014) Serial brain 18FDG-PET in anti-AMPA receptor limbic encephalitis. J Neuroimmunol 271:53\u201355. \n                    https:\/\/doi.org\/10.1016\/j.jneuroim.2014.04.002","journal-title":"J Neuroimmunol"},{"key":"3930_CR84","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/RLU.0000000000000546","volume":"40","author":"S Park","year":"2015","unstructured":"Park S, Choi H, Cheon GJ et al (2015) 18F-FDG PET\/CT in anti-LGI1 encephalitis: initial and follow-up findings. Clin Nucl Med 40:156\u2013158. \n                    https:\/\/doi.org\/10.1097\/RLU.0000000000000546","journal-title":"Clin Nucl Med"},{"key":"3930_CR85","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/ana.23932","volume":"74","author":"C Finke","year":"2013","unstructured":"Finke C, Kopp UA, Scheel M et al (2013) Functional and structural brain changes in anti-N-methyl-D-aspartate receptor encephalitis. Ann Neurol 74:284\u2013296. \n                    https:\/\/doi.org\/10.1002\/ana.23932","journal-title":"Ann Neurol"},{"key":"3930_CR86","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1093\/brain\/aww012","volume":"139","author":"V Navarro","year":"2016","unstructured":"Navarro V, Kas A, Apartis E et al (2016) Motor cortex and hippocampus are the two main cortical targets in LGI1-antibody encephalitis. Brain 139:1079\u20131093. \n                    https:\/\/doi.org\/10.1093\/brain\/aww012","journal-title":"Brain"},{"key":"3930_CR87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0161656","volume":"11","author":"K Kothur","year":"2016","unstructured":"Kothur K, Wienholt L, Mohammad SS et al (2016) Utility of CSF cytokine\/chemokines as markers of active intrathecal inflammation: comparison of demyelinating, anti-NMDAR and enteroviral encephalitis. PLoS One 11:1\u201319. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0161656","journal-title":"PLoS One"},{"key":"3930_CR88","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10072-017-3032-4","volume":"38","author":"L Zuliani","year":"2017","unstructured":"Zuliani L, Zoccarato M, Gastaldi M et al (2017) Diagnostics of autoimmune encephalitis associated with antibodies against neuronal surface antigens. Neurol Sci 38:225\u2013229. \n                    https:\/\/doi.org\/10.1007\/s10072-017-3032-4","journal-title":"Neurol Sci"},{"key":"3930_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/NXI.0000000000000404","volume":"4","author":"L McCracken","year":"2017","unstructured":"McCracken L, Zhang J, Greene M et al (2017) Improving the antibody-based evaluation of autoimmune encephalitis. Neurol Neuroimmunol NeuroInflammation 4:1\u20137. \n                    https:\/\/doi.org\/10.1212\/NXI.0000000000000404","journal-title":"Neurol Neuroimmunol NeuroInflammation"},{"key":"3930_CR90","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1474-4422(13)70282-5","volume":"13","author":"N Gresa-Arribas","year":"2014","unstructured":"Gresa-Arribas N, Titulaer MJ, Torrents A et al (2014) Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol 13:167\u2013177. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(13)70282-5","journal-title":"Lancet Neurol"},{"key":"3930_CR91","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.clinbiochem.2016.11.023","volume":"50","author":"M Gastaldi","year":"2017","unstructured":"Gastaldi M, Thouin A, Franciotta D, Vincent A (2017) Pitfalls in the detection of N-methyl-D-aspartate-receptor (NMDA-R) antibodies. Clin Biochem 50:354\u2013355. \n                    https:\/\/doi.org\/10.1016\/j.clinbiochem.2016.11.023","journal-title":"Clin Biochem"},{"key":"3930_CR92","doi-asserted-by":"publisher","unstructured":"Mariotto S, Andreetta F, Farinazzo A et al (2017) Persistence of anti-NMDAR antibodies in CSF after recovery from autoimmune encephalitis. Neurol Sci. \n                    https:\/\/doi.org\/10.1007\/s10072-017-2958-x","DOI":"10.1007\/s10072-017-2958-x"},{"key":"3930_CR93","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1212\/WNL.0000000000002637","volume":"86","author":"A Van Sonderen","year":"2016","unstructured":"Van Sonderen A, Schreurs MWJ, De Bruijn MAAM et al (2016) The relevance of VGKC positivity in the absence of LGI1 and Caspr2 antibodies. Neurology 86:1692\u20131699. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000002637","journal-title":"Neurology"},{"key":"3930_CR94","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1136\/jnnp-2016-314758","volume":"88","author":"B Lang","year":"2017","unstructured":"Lang B, Makuch M, Moloney T, Dettmann I, Mindorf S, Probst C, Stoecker W, Buckley C, Newton CR, Leite MI, Maddison P, Komorowski L, Adcock J, Vincent A, Waters P, Irani SR (2017) Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies. J Neurol Neurosurg Psychiatry 88:353\u2013361. \n                    https:\/\/doi.org\/10.1136\/jnnp-2016-314758","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3930_CR95","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","volume":"75","author":"F Graus","year":"2004","unstructured":"Graus F, Delattre JY, Antoine J-C et al (2004) Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 75:1135\u20131141. \n                    https:\/\/doi.org\/10.1136\/jnnp.2003.034447","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"(Suppl 2)","key":"3930_CR96","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s10072-017-3031-5","volume":"38","author":"M Zoccarato","year":"2017","unstructured":"Zoccarato M, Gastaldi M, Zuliani L et al (2017) Diagnostics of paraneoplastic neurological syndromes. Neurol Sci 38(Suppl 2):237\u2013242. \n                    https:\/\/doi.org\/10.1007\/s10072-017-3031-5","journal-title":"Neurol Sci"},{"key":"3930_CR97","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10072-017-3027-1","volume-title":"Diagnostics of the neuromyelitis optica spectrum disorders (NMOSD)","author":"D Franciotta","year":"2017","unstructured":"Franciotta D, Gastaldi M, Sala A, et al (2017) Diagnostics of the neuromyelitis optica spectrum disorders (NMOSD). 38:231\u2013236. \n                    https:\/\/doi.org\/10.1007\/s10072-017-3027-1"},{"key":"3930_CR98","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12883-017-0971-6","volume":"17","author":"S Mariotto","year":"2017","unstructured":"Mariotto S, Monaco S, Peschl P et al (2017) MOG antibody seropositivity in a patient with encephalitis: beyond the classical syndrome. BMC Neurol 17:6\u201311. \n                    https:\/\/doi.org\/10.1186\/s12883-017-0971-6","journal-title":"BMC Neurol"},{"key":"3930_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-018-1144-2","volume":"15","author":"S Jarius","year":"2018","unstructured":"Jarius S, Paul F, Aktas O et al (2018) MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. J Neuroinflammation 15:1\u201310. \n                    https:\/\/doi.org\/10.1186\/s12974-018-1144-2","journal-title":"J Neuroinflammation"},{"key":"3930_CR100","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1136\/jnnp-2017-316583","volume":"89","author":"R Iorio","year":"2018","unstructured":"Iorio R, Damato V, Evoli A et al (2018) Clinical and immunological characteristics of the spectrum of GFAP autoimmunity: a case series of 22 patients. J Neurol Neurosurg Psychiatry 89:138\u2013146. \n                    https:\/\/doi.org\/10.1136\/jnnp-2017-316583","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3930_CR101","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1468-1331.2010.03220.x","volume":"18","author":"MJ Titulaer","year":"2011","unstructured":"Titulaer MJ, Soffietti R, Dalmau J et al (2011) Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. Eur J Neurol 18:19\u201327. \n                    https:\/\/doi.org\/10.1111\/j.1468-1331.2010.03220.x","journal-title":"Eur J Neurol"},{"key":"3930_CR102","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1111\/dmcn.13579","volume":"59","author":"ACC Ho","year":"2017","unstructured":"Ho ACC, Mohammad SS, Pillai SC et al (2017) High sensitivity and specificity in proposed clinical diagnostic criteria for anti-N-methyl-D-aspartate receptor encephalitis. Dev Med Child Neurol 59:1256\u20131260. \n                    https:\/\/doi.org\/10.1111\/dmcn.13579","journal-title":"Dev Med Child Neurol"},{"key":"3930_CR103","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1111\/dmcn.13169","volume":"58","author":"Y Hacohen","year":"2016","unstructured":"Hacohen Y, Wright S, Gadian J et al (2016) N-methyl-d-aspartate (NMDA) receptor antibodies encephalitis mimicking an autistic regression. Dev Med Child Neurol 58:1092\u20131094. \n                    https:\/\/doi.org\/10.1111\/dmcn.13169","journal-title":"Dev Med Child Neurol"},{"issue":"8","key":"3930_CR104","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1001\/archneurol.2011.166","volume":"68","author":"JH Smith","year":"2011","unstructured":"Smith JH, Dhamija R, Moseley BD, Sandroni P, Lucchinetti CF, Lennon VA, Kantarci OH (2011) N-methyl-D-aspartate receptor autoimmune encephalitis presenting with opsoclonus-myoclonus. Arch Neurol 68(8):1069\u20131072. \n                    https:\/\/doi.org\/10.1001\/archneurol.2011.166","journal-title":"Arch Neurol"},{"key":"3930_CR105","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1212\/NXI.0000000000000002","volume":"1","author":"Y Hacohen","year":"2014","unstructured":"Hacohen Y, Absoud M, Hemingway C et al (2014) NMDA receptor antibodies associated with distinct white matter syndromes. Neurol Neuroimmunol neuroinflammation 1:e2. \n                    https:\/\/doi.org\/10.1212\/NXI.0000000000000002","journal-title":"Neurol Neuroimmunol neuroinflammation"},{"key":"3930_CR106","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ejpn.2017.12.009","volume":"22","author":"M Carecchio","year":"2018","unstructured":"Carecchio M, Zorzi G, Ragona F et al (2018) ATP1A3-related disorders: an update. Eur J Paediatr Neurol 22:257\u2013263. \n                    https:\/\/doi.org\/10.1016\/j.ejpn.2017.12.009","journal-title":"Eur J Paediatr Neurol"},{"key":"3930_CR107","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.ejpn.2015.02.006","volume":"19","author":"S Sartori","year":"2015","unstructured":"Sartori S, Nosadini M, Cesaroni E et al (2015) Paediatric anti-N-methyl-d-aspartate receptor encephalitis: the first Italian multicenter case series. Eur J Paediatr Neurol 19:453\u2013463. \n                    https:\/\/doi.org\/10.1016\/j.ejpn.2015.02.006","journal-title":"Eur J Paediatr Neurol"},{"key":"3930_CR108","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s00415-016-8056-9","volume":"263","author":"S Matricardi","year":"2016","unstructured":"Matricardi S, Patrini M, Freri E, Ragona F, Zibordi F, Andreetta F, Nardocci N, Granata T (2016) Cognitive and neuropsychological evolution in children with anti-NMDAR encephalitis. J Neurol 263:765\u2013771. \n                    https:\/\/doi.org\/10.1007\/s00415-016-8056-9","journal-title":"J Neurol"},{"key":"3930_CR109","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S1474-4422(12)70319-8","volume":"12","author":"A McKeon","year":"2013","unstructured":"McKeon A (2013) The importance of early and sustained treatment of a common autoimmune encephalitis. Lancet Neurol 12:123\u2013125. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(12)70319-8","journal-title":"Lancet Neurol"},{"key":"3930_CR110","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1586\/14737175.2015.1115720","volume":"15","author":"M Nosadini","year":"2015","unstructured":"Nosadini M, Mohammad SS, Ramanathan S et al (2015) Immune therapy in autoimmune encephalitis: a systematic review. Expert Rev Neurother 15:1391\u20131419. \n                    https:\/\/doi.org\/10.1586\/14737175.2015.1115720","journal-title":"Expert Rev Neurother"},{"key":"3930_CR111","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s13311-015-0410-6","volume":"13","author":"M Gastaldi","year":"2016","unstructured":"Gastaldi M, Thouin A, Vincent A (2016) Antibody-mediated autoimmune encephalopathies and immunotherapies. Neurotherapeutics 13:147\u2013162. \n                    https:\/\/doi.org\/10.1007\/s13311-015-0410-6","journal-title":"Neurotherapeutics"},{"issue":"1","key":"3930_CR112","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3988\/jcn.2016.12.1.1","volume":"12","author":"E Lancaster","year":"2016","unstructured":"Lancaster E (2016) The diagnosis and treatment of autoimmune encephalitis. J Clin Neurol 12(1):13. \n                    https:\/\/doi.org\/10.3988\/jcn.2016.12.1.1","journal-title":"J Clin Neurol"},{"key":"3930_CR113","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/WCO.0000000000000443","volume":"30","author":"RC Dale","year":"2017","unstructured":"Dale RC, Gorman MP, Lim M (2017) Autoimmune encephalitis in children: clinical phenomenology, therapeutics, and emerging challenges. Curr Opin Neurol 30:334\u2013344. \n                    https:\/\/doi.org\/10.1097\/WCO.0000000000000443","journal-title":"Curr Opin Neurol"},{"key":"3930_CR114","doi-asserted-by":"publisher","unstructured":"Nosadini M, Mohammad SS, Suppiej A et al (2016) Intravenous immunoglobulin in paediatric neurology: safety, adherence to guidelines, and long-term outcome. Dev Med Child Neurol:1\u201313. \n                    https:\/\/doi.org\/10.1111\/dmcn.13159","DOI":"10.1111\/dmcn.13159"},{"key":"3930_CR115","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/dmcn.13349","volume":"59","author":"J Gadian","year":"2017","unstructured":"Gadian J, Kirk E, Holliday K et al (2017) Systematic review of immunoglobulin use in paediatric neurological and neurodevelopmental disorders. Dev Med Child Neurol 59:136\u2013144. \n                    https:\/\/doi.org\/10.1111\/dmcn.13349","journal-title":"Dev Med Child Neurol"},{"key":"3930_CR116","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.braindev.2016.01.009","volume":"38","author":"A Suppiej","year":"2016","unstructured":"Suppiej A, Nosadini M, Zuliani L, Pelizza MF, Toldo I, Bertossi C, Tison T, Zoccarato M, Marson P, Giometto B, Dale RC, Sartori S (2016) Plasma exchange in pediatric anti-NMDAR encephalitis: a systematic review. Brain and Development 38:613\u2013622. \n                    https:\/\/doi.org\/10.1016\/j.braindev.2016.01.009","journal-title":"Brain and Development"},{"key":"3930_CR117","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1093\/brain\/awh077","volume":"127","author":"A Vincent","year":"2004","unstructured":"Vincent A, Buckley C, Schott JM et al (2004) Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 127:701\u2013712. \n                    https:\/\/doi.org\/10.1093\/brain\/awh077","journal-title":"Brain"},{"key":"3930_CR118","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1111\/dmcn.12411","volume":"56","author":"S Byrne","year":"2014","unstructured":"Byrne S, Mccoy B, Lynch B et al (2014) Does early treatment improve outcomes in N-methyl-D-aspartate receptor encephalitis? Dev Med Child Neurol 56:794\u2013796. \n                    https:\/\/doi.org\/10.1111\/dmcn.12411","journal-title":"Dev Med Child Neurol"},{"key":"3930_CR119","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/dmcn.12559","volume":"57","author":"S Byrne","year":"2015","unstructured":"Byrne S, Lim M (2015) N-methyl-d-aspartate receptor antibody encephalitis: how much treatment is enough? Dev Med Child Neurol 57:14\u201315. \n                    https:\/\/doi.org\/10.1111\/dmcn.12559","journal-title":"Dev Med Child Neurol"},{"key":"3930_CR120","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1093\/brain\/awq113","volume":"133","author":"SR Irani","year":"2010","unstructured":"Irani SR, Bera K, Waters P et al (2010) N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 133:1655\u20131667. \n                    https:\/\/doi.org\/10.1093\/brain\/awq113","journal-title":"Brain"},{"key":"3930_CR121","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1212\/WNL.0000000000000570","volume":"83","author":"RC Dale","year":"2014","unstructured":"Dale RC, Brilot F, Duffy LV et al (2014) Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease. Neurology 83:142\u2013150. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000000570","journal-title":"Neurology"},{"key":"3930_CR122","doi-asserted-by":"publisher","unstructured":"Thompson J, Bi M, Murchison AG, et al (2018) The importance of early immunotherapy in patients with faciobrachial dystonic seizures. 348\u2013356. \n                    https:\/\/doi.org\/10.1093\/brain\/awx323","DOI":"10.1093\/brain\/awx323"},{"key":"3930_CR123","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/ana.24200","volume":"76","author":"SR Irani","year":"2014","unstructured":"Irani SR, Gelfand JM, Al-Diwani A, Vincent A (2014) Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms. Ann Neurol 76:168\u2013184. \n                    https:\/\/doi.org\/10.1002\/ana.24200","journal-title":"Ann Neurol"},{"key":"3930_CR124","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nrneurol.2017.43","volume":"13","author":"A van Sonderen","year":"2017","unstructured":"van Sonderen A, Petit-Pedrol M, Dalmau J, Titulaer MJ (2017) The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis. Nat Rev Neurol 13:290\u2013301. \n                    https:\/\/doi.org\/10.1038\/nrneurol.2017.43","journal-title":"Nat Rev Neurol"},{"key":"3930_CR125","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/ene.13180","volume":"24","author":"CG Bien","year":"2017","unstructured":"Bien CG, Mirzadjanova Z, Baumgartner C et al (2017) Anti-contactin-associated protein-2 encephalitis: relevance of antibody titres, presentation and outcome. Eur J Neurol 24:175\u2013186. \n                    https:\/\/doi.org\/10.1111\/ene.13180","journal-title":"Eur J Neurol"},{"key":"3930_CR126","doi-asserted-by":"publisher","unstructured":"Pittock SJ, Palace J (2016) Paraneoplastic and idiopathic autoimmune neurologic disorders: approach to diagnosis and treatment. Handb Clin Neurol 133:165\u2013183. \n                    https:\/\/doi.org\/10.1016\/B978-0-444-63432-0.00010-4","DOI":"10.1016\/B978-0-444-63432-0.00010-4"},{"key":"3930_CR127","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1212\/WNL.0000000000000383","volume":"82","author":"M Toledano","year":"2014","unstructured":"Toledano M, Britton JW, McKeon A, Shin C, Lennon VA, Quek AML, So E, Worrell GA, Cascino GD, Klein CJ, Lagerlund TD, Wirrell EC, Nickels KC, Pittock SJ (2014) Utility of an immunotherapy trial in evaluating patients with presumed autoimmune epilepsy. Neurology 82:1578\u20131586. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000000383","journal-title":"Neurology"},{"key":"3930_CR128","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/ana.25421","volume":"83","author":"J Lim","year":"2019","unstructured":"Lim J, Lee S, Moon J et al (2019) Development of the clinical assessment scale in autoimmune encephalitis (CASE). Ann Neurol 83:352\u2013358. \n                    https:\/\/doi.org\/10.1002\/ana.25421","journal-title":"Ann Neurol"},{"key":"3930_CR129","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/dmcn.12036","volume":"55","author":"RC Dale","year":"2013","unstructured":"Dale RC, Pillai S, Brilot F (2013) Cerebrospinal fluid CD19+ B-cell expansion in N-methyl-D-aspartate receptor encephalitis. Dev Med Child Neurol 55:191\u2013193. \n                    https:\/\/doi.org\/10.1111\/dmcn.12036","journal-title":"Dev Med Child Neurol"},{"key":"3930_CR130","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1212\/WNL.0000000000002635","volume":"86","author":"WJ Lee","year":"2016","unstructured":"Lee WJ, Lee ST, Byun JI et al (2016) Rituximab treatment for autoimmune limbic encephalitis in an institutional cohort. Neurology 86:1683\u20131691. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000002635","journal-title":"Neurology"},{"key":"3930_CR131","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1212\/WNL.0000000000003536","volume":"88","author":"F Scheibe","year":"2016","unstructured":"Scheibe F, Pr\u00fcss H, Mengel AM et al (2016) Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitis. Neurology 88:366\u2013379. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000003536","journal-title":"Neurology"},{"key":"3930_CR132","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1001\/jamaneurol.2016.2588.jamaneurology.com","volume":"73","author":"V Behrendt","year":"2016","unstructured":"Behrendt V, Krogias C, Reinacher-Schick A et al (2016) Bortezomib treatment for patients with anti-N-methyl-D-aspartate receptor encephalitis. JAMA Neurol 73:1251\u20131253. \n                    https:\/\/doi.org\/10.1001\/jamaneurol.2016.2588.jamaneurology.com","journal-title":"JAMA Neurol"},{"key":"3930_CR133","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1007\/s13311-016-0442-6","volume":"13","author":"WJ Lee","year":"2016","unstructured":"Lee WJ, Lee ST, Moon J et al (2016) Tocilizumab in autoimmune encephalitis refractory to rituximab: an institutional cohort study. Neurotherapeutics 13:824\u2013832. \n                    https:\/\/doi.org\/10.1007\/s13311-016-0442-6","journal-title":"Neurotherapeutics"},{"key":"3930_CR134","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/dmcn.12545","volume":"57","author":"S Tatencloux","year":"2015","unstructured":"Tatencloux S, Chretien P, Rogemond V et al (2015) Intrathecal treatment of anti-N-methyl-d-aspartate receptor encephalitis in children. Dev Med Child Neurol 57:95\u201399. \n                    https:\/\/doi.org\/10.1111\/dmcn.12545","journal-title":"Dev Med Child Neurol"},{"key":"3930_CR135","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/ana.25374","volume":"84","author":"J Jun","year":"2018","unstructured":"Jun J, Lee S, Kim R et al (2018) Tocilizumab treatment for new-onset refractory status epilepticus. Ann Neurol 84:940\u2013945. \n                    https:\/\/doi.org\/10.1002\/ana.25374","journal-title":"Ann Neurol"},{"key":"3930_CR136","doi-asserted-by":"publisher","unstructured":"Nosadini M, Mohammad SS, Toldo I, et al (2018) Mycophenolate mofetil, azathioprine and methotrexate usage in paediatric anti-NMDAR encephalitis: a systematic literature review. Eur J Paediatr Neurol 1\u201312. \n                    https:\/\/doi.org\/10.1016\/j.ejpn.2018.09.008","DOI":"10.1016\/j.ejpn.2018.09.008"},{"key":"3930_CR137","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1136\/jnnp-2011-300411","volume":"83","author":"C Finke","year":"2012","unstructured":"Finke C, Kopp UA, Pr\u00fcss H et al (2012) Cognitive deficits following anti-NMDA receptor encephalitis. J Neurol Neurosurg Psychiatry 83:195\u2013198. \n                    https:\/\/doi.org\/10.1136\/jnnp-2011-300411","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3930_CR138","doi-asserted-by":"publisher","first-page":"e244","DOI":"10.1212\/WNL.0000000000006783","volume":"92","author":"R Balu","year":"2019","unstructured":"Balu R, Mccracken L, Lancaster E, Graus F (2019) A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis. Neurology 92:e244\u2013e252. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000006783","journal-title":"Neurology"},{"key":"3930_CR139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamaneurol.2016.4226","volume-title":"Evaluation of cognitive deficits and structural hippocampal damage in encephalitis with leucine-rich, glioma-inactivated 1 antibodies","author":"C Finke","year":"2016","unstructured":"Finke C, Pr\u00fcss H, Heine J et al (2016) Evaluation of cognitive deficits and structural hippocampal damage in encephalitis with leucine-rich, glioma-inactivated 1 antibodies, pp 1\u201310. \n                    https:\/\/doi.org\/10.1001\/jamaneurol.2016.4226"},{"key":"3930_CR140","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1212\/WNL.0b013e31822cfc6b","volume":"77","author":"I Gabilondo","year":"2011","unstructured":"Gabilondo I, Saiz A, Gal\u00e1n L et al (2011) Analysis of relapses in anti-NMDAR encephalitis. Neurology 77:996\u2013999. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e31822cfc6b","journal-title":"Neurology"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-019-03930-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-019-03930-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-019-03930-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T21:03:09Z","timestamp":1591045389000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-019-03930-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,3]]},"references-count":140,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["3930"],"URL":"https:\/\/doi.org\/10.1007\/s10072-019-03930-3","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,3]]},"assertion":[{"value":"17 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"No competing interests have been identified.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}